Measuring ADHD Symptoms with QbTest - in Conversation with Dr. Heather Brannon

Dr. Heather Brannon, MD is a family physician with 26 years of experience. She dedicated her practice to ADHD care 9 years ago.

She discusses the importance of measuring ADHD symptoms with an objective test in order to aid in the evaluation.

Her practice was among the first to adopt Telehealth during the pandemic. This is their experience.

0: 00 Why did you choose to specialize in ADHD?
0: 40 What did QbTest do for you?
1: 21 What did COVID mean for you?
1: 51 What did QbTest’s Telehealth version do?

Learn more about our work at

Follow us on social media!

Twitter: D
LinkedIn: /
Facebook: D

Get the latest updates by signing up

http://medbusiness.net/measuring-adhd-symptoms-with-qbtest-in-conversation-with-dr-heather-brannon/

Join our live Google Hangout with our panel:
Nicoletta Adamo (London, UK)
Samuele Cortese (Southampton, UK)
Franco De Crescenzo (Rome, Italy)
Stephen Faraone (SUNY, USA)
Sandra Kooij (PsyQ, The Netherlands)
Andrea Cipriani (Oxford, UK)
Michael Ostacher (Stanford, USA)

Attention-deficit/hyperactivity disorder (ADHD) is characterised by a persistent and impairing pattern of inattention and/or hyperactivity/impulsivity and it is one of the most common neuropsychiatric conditions. Evidence about interventions of adults with ADHD is growing rapidly. The panel will discuss a recent meta-review of Pharmacological and non-pharmacological treatment of adults with ADHD. This research will provide the starting point for wide-ranging discussion and debate, including a focus on the implications for practice and future research.



The paper which will be discussed is:
De Crescenzo F, Cortese S, Adamo N, et al Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review Evidence-Based Mental Health Published Online First: 19 December 2016. doi: 10.1136/eb-2016-102415
4